Wellcome Trust’s Johnson & Johnson JNJ Stock Holding History

Wellcome Trust’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$406M	Hold	1,600,000	–	–	4.51%	12
2026 Q1	$391M	Hold	1,600,000	–	–	4.83%	11
2025 Q4	$331M	Hold	1,600,000	–	–	3.55%	15
2025 Q3	$297M	Hold	1,600,000	–	–	3.23%	15
2025 Q2	$244M	Hold	1,600,000	–	–	2.82%	18
2025 Q1	$265M	Hold	1,600,000	–	–	3.32%	18
2024 Q4	$231M	Hold	1,600,000	–	–	2.8%	18
2024 Q3	$259M	Hold	1,600,000	–	–	3.16%	19
2024 Q2	$234M	Sell	1,600,000 -100,000	-6%	-$14.9M	2.99%	18
2024 Q1	$269M	Hold	1,700,000	–	–	3.23%	17
2023 Q4	$266M	Sell	1,700,000 -400,000	-19%	-$61.3M	3.3%	16
2023 Q3	$327M	Sell	2,100,000 -280,000	-12%	-$46.2M	4.35%	11
2023 Q2	$394M	Hold	2,380,000	–	–	5.19%	8
2023 Q1	$369M	Hold	2,380,000	–	–	5.15%	7
2022 Q4	$420M	Hold	2,380,000	–	–	6.22%	4
2022 Q3	$389M	Hold	2,380,000	–	–	6.09%	5
2022 Q2	$422M	Hold	2,380,000	–	–	5.51%	5
2022 Q1	$422M	Hold	2,380,000	–	–	4.41%	7
2021 Q4	$407M	Buy	2,380,000 +160,000	+7%	+$26.2M	3.86%	14
2021 Q3	$359M	Hold	2,220,000	–	–	3.54%	14
2021 Q2	$366M	Hold	2,220,000	–	–	3.49%	14
2021 Q1	$365M	Buy	2,220,000 +220,000	+11%	+$35.6M	3.81%	11
2020 Q4	$315M	Hold	2,000,000	–	–	3.22%	11
2020 Q3	$298M	Hold	2,000,000	–	–	4.03%	8
2020 Q2	$281M	Hold	2,000,000	–	–	4.27%	9
2020 Q1	$262M	Hold	2,000,000	–	–	4.69%	10
2019 Q4	$292M	Buy	2,000,000 +300,000	+18%	+$40.7M	3.91%	11
2019 Q3	$220M	Hold	1,700,000	–	–	3.48%	13
2019 Q2	$237M	Hold	1,700,000	–	–	3.68%	14
2019 Q1	$238M	Hold	1,700,000	–	–	3.85%	14
2018 Q4	$219M	Hold	1,700,000	–	–	4.15%	10
2018 Q3	$235M	Hold	1,700,000	–	–	3.71%	11
2018 Q2	$206M	Hold	1,700,000	–	–	3.31%	13
2018 Q1	$218M	Hold	1,700,000	–	–	3.28%	13
2017 Q4	$238M	Hold	1,700,000	–	–	3.59%	14
2017 Q3	$221M	Hold	1,700,000	–	–	3.53%	15
2017 Q2	$225M	Hold	1,700,000	–	–	3.83%	13
2017 Q1	$212M	Hold	1,700,000	–	–	3.81%	16
2016 Q4	$196M	Hold	1,700,000	–	–	3.92%	15
2016 Q3	$201M	Hold	1,700,000	–	–	4.2%	15
2016 Q2	$206M	Hold	1,700,000	–	–	4.69%	12
2016 Q1	$184M	Sell	1,700,000 -50,000	-3%	-$5.18M	4.07%	14
2015 Q4	$180M	Hold	1,750,000	–	–	3.58%	14
2015 Q3	$163M	Hold	1,750,000	–	–	3.61%	15
2015 Q2	$171M	Hold	1,750,000	–	–	3.45%	16
2015 Q1	$176M	Buy	1,750,000 +20,000	+1%	+$2.03M	3.78%	15
2014 Q4	$181M	Hold	1,730,000	–	–	3.73%	14
2014 Q3	$184M	Buy	1,730,000 +80,000	+5%	+$8.3M	3.82%	14
2014 Q2	$173M	Hold	1,650,000	–	–	4.16%	13
2014 Q1	$162M	Hold	1,650,000	–	–	3.99%	14
2013 Q4	$151M	Hold	1,650,000	–	–	4%	13
2013 Q3	$143M	Hold	1,650,000	–	–	4.71%	14
2013 Q2	$142M	Buy	+1,650,000	New	+$140M	5.01%	11

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wellcome Trust's JNJ Position: Q2 2026 in Review

Wellcome Trust held its Johnson & Johnson (JNJ) position steady in Q2 2026 at 1,600,000 shares worth $406M. The position accounts for 4.51% of the portfolio, ranked #12.

Wellcome Trust first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $422M in Q2 2022. 4,672 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

Wellcome Trust held 1,600,000 shares of Johnson & Johnson worth $406M as of Q2 2026.
Wellcome Trust left its Johnson & Johnson share count unchanged in Q2 2026.
Johnson & Johnson made up 4.51% of Wellcome Trust's portfolio in Q2 2026, its #12 holding.
Wellcome Trust first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
Wellcome Trust's Johnson & Johnson position peaked at $422M in Q2 2022.
4,672 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Wellcome Trust's 13F filing for Q2 2026, filed 9 Jul 2026.